G I Bell1, D M Putman, J M Hughes-Large, D A Hess. 1. Program in Regenerative Medicine, Krembil Centre for Stem Cell Biology, Vascular Biology Group, Robarts Research Institute, Department of Physiology and Pharmacology, University of Western Ontario, PO Box 5015, 100 Perth Drive, London, ON, Canada N6A 5K8.
Abstract
AIMS/HYPOTHESIS: We sought to investigate the stimulation of islet regeneration by transplanted human umbilical cord blood (UCB) cells purified according to high aldehyde dehydrogenase (ALDH) activity (ALDH(hi)), a conserved characteristic of multiple progenitor lineages. We hypothesised that direct intrapancreatic (iPan) delivery of ALDH(hi) progenitors would augment islet regeneration via timely and localised exposure to islet-regenerative stimuli. METHODS: Cells were purified from UCB based on flow cytometry for low ALDH activity (ALDH(lo)) vs ALDH(hi). UCB ALDH(lo) or ALDH(hi) cells were compared for surface marker expression, as well as haematopoietic, endothelial and multipotent stromal progenitor content in vitro. UCB ALDH(lo) or ALDH(hi) cells were i.v. or iPan injected into streptozotocin-treated non-obese diabetic/severe combined immune-deficient mice temporally monitored for blood glucose, serum insulin and glucose tolerance. Human cell recruitment and survival in the pancreas, insulin content, islet-associated cell proliferation and islet vascularisation were documented in situ. RESULTS: UCB-derived ALDH(hi) cells were highly enriched for haematopoietic and endothelial progenitor frequency, and showed increased expression of progenitor and myeloid cell surface markers. Although i.v. transplantation of ALDH(hi) cells demonstrated low pancreas engraftment and only transient blood glucose lowering capacity, iPan injected ALDH(hi) cells reversed established hyperglycaemia, increased serum insulin and improved the response to a glucose challenge. iPan injected ALDH(hi) cells surrounded damaged islets at early time points and increased islet-associated cell proliferation, resulting in the recovery of beta cell mass. CONCLUSIONS/ INTERPRETATION: iPan delivery of UCB ALDH(hi) cells potentiated islet-associated cell proliferation, insulin production and islet revascularisation, resulting in the recovery of host islet function. Elucidation of the progenitor-specific pathways stimulated during islet regeneration may provide new approaches to promote islet expansion during diabetes.
AIMS/HYPOTHESIS: We sought to investigate the stimulation of islet regeneration by transplanted human umbilical cord blood (UCB) cells purified according to high aldehyde dehydrogenase (ALDH) activity (ALDH(hi)), a conserved characteristic of multiple progenitor lineages. We hypothesised that direct intrapancreatic (iPan) delivery of ALDH(hi) progenitors would augment islet regeneration via timely and localised exposure to islet-regenerative stimuli. METHODS: Cells were purified from UCB based on flow cytometry for low ALDH activity (ALDH(lo)) vs ALDH(hi). UCB ALDH(lo) or ALDH(hi) cells were compared for surface marker expression, as well as haematopoietic, endothelial and multipotent stromal progenitor content in vitro. UCB ALDH(lo) or ALDH(hi) cells were i.v. or iPan injected into streptozotocin-treated non-obese diabetic/severe combined immune-deficient mice temporally monitored for blood glucose, serum insulin and glucose tolerance. Human cell recruitment and survival in the pancreas, insulin content, islet-associated cell proliferation and islet vascularisation were documented in situ. RESULTS: UCB-derived ALDH(hi) cells were highly enriched for haematopoietic and endothelial progenitor frequency, and showed increased expression of progenitor and myeloid cell surface markers. Although i.v. transplantation of ALDH(hi) cells demonstrated low pancreas engraftment and only transient blood glucose lowering capacity, iPan injected ALDH(hi) cells reversed established hyperglycaemia, increased serum insulin and improved the response to a glucose challenge. iPan injected ALDH(hi) cells surrounded damaged islets at early time points and increased islet-associated cell proliferation, resulting in the recovery of beta cell mass. CONCLUSIONS/ INTERPRETATION:iPan delivery of UCB ALDH(hi) cells potentiated islet-associated cell proliferation, insulin production and islet revascularisation, resulting in the recovery of host islet function. Elucidation of the progenitor-specific pathways stimulated during islet regeneration may provide new approaches to promote islet expansion during diabetes.
Authors: David Hess; Li Li; Matthew Martin; Seiji Sakano; David Hill; Brenda Strutt; Sandra Thyssen; Douglas A Gray; Mickie Bhatia Journal: Nat Biotechnol Date: 2003-06-22 Impact factor: 54.908
Authors: Gillian I Bell; Heather C Broughton; Krysta D Levac; David A Allan; Anargyros Xenocostas; David A Hess Journal: Stem Cells Dev Date: 2011-10-21 Impact factor: 3.272
Authors: E Snarski; A Milczarczyk; T Torosian; M Paluszewska; E Urbanowska; M Król; P Boguradzki; K Jedynasty; E Franek; W Wiktor-Jedrzejczak Journal: Bone Marrow Transplant Date: 2010-06-28 Impact factor: 5.483
Authors: Ryang Hwa Lee; Min Jeong Seo; Roxanne L Reger; Jeffrey L Spees; Andrey A Pulin; Scott D Olson; Darwin J Prockop Journal: Proc Natl Acad Sci U S A Date: 2006-11-06 Impact factor: 11.205
Authors: Hillary A Keenan; Jennifer K Sun; Jared Levine; Alessandro Doria; Lloyd P Aiello; George Eisenbarth; Susan Bonner-Weir; George L King Journal: Diabetes Date: 2010-08-10 Impact factor: 9.461
Authors: David A Hess; Todd E Meyerrose; Louisa Wirthlin; Timothy P Craft; Phillip E Herrbrich; Michael H Creer; Jan A Nolta Journal: Blood Date: 2004-06-03 Impact factor: 22.113
Authors: Benjamin J Capoccia; Debra L Robson; Krysta D Levac; Dustin J Maxwell; Sarah A Hohm; Marian J Neelamkavil; Gillian I Bell; Anargyros Xenocostas; Daniel C Link; David Piwnica-Worms; Jan A Nolta; David A Hess Journal: Blood Date: 2009-03-26 Impact factor: 22.113
Authors: Simon R Smukler; Margot E Arntfield; Rozita Razavi; George Bikopoulos; Phillip Karpowicz; Raewyn Seaberg; Feihan Dai; Simon Lee; Rosemary Ahrens; Paul E Fraser; Michael B Wheeler; Derek van der Kooy Journal: Cell Stem Cell Date: 2011-03-04 Impact factor: 24.633
Authors: Michael J Haller; Clive H Wasserfall; Maigan A Hulme; Miriam Cintron; Todd M Brusko; Kieran M McGrail; Theresa M Sumrall; John R Wingard; Douglas W Theriaque; Jonathan J Shuster; Mark A Atkinson; Desmond A Schatz Journal: Diabetes Care Date: 2011-10-19 Impact factor: 19.112
Authors: Edith J Arany; Muhammad Waseem; Brenda J Strutt; Astrid Chamson-Reig; Adam Bernardo; Elizabeth Eng; David J Hill Journal: Islets Date: 2018-08-15 Impact factor: 2.694
Authors: Tatsuyoshi M Kono; Emily K Sims; Dan R Moss; Wataru Yamamoto; Geonyoung Ahn; Julie Diamond; Xin Tong; Kathleen H Day; Paul R Territo; Helmut Hanenberg; Dmitry O Traktuev; Keith L March; Carmella Evans-Molina Journal: Stem Cells Date: 2014-07 Impact factor: 6.277